Next, we investigated whether a TNF inhibitor (etanercept), most commonly used in RA therapy, could restore the pPDGFRαβ/CDH11 ratio after 2GF + TNF stimulation (Figure 6). This evidence concerns the gene TNF and rheumatoid arthritis.